Heron Therapeutics, Inc.
HRTXDrugs in Pipeline
13
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How HRTX's past catalysts played out
APF530
Nausea and Vomiting
HTX-011
Postoperative Pain
Bupivacaine HCl
Postoperative Pain
Bupivicaine HCl
Postoperative Pain
HTX-034
Bunions
Bupivacaine HCI (Marcaine)
Postoperative Pain
aprepitant
Postoperative Pain
Bupivacaine HCI without epinephrine
Post-Operative Pain
Ketorolac
Postoperative Pain
HTX-011B
Postoperative Pain
B10 L-BPA Injection
Meningioma
HTX-011A
Postoperative Pain
Bupivacaine HCl without epinephrine
Postoperative Pain
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
APF530 | Phase 3 | Nausea and Vomiting | - | - |
HTX-011 | Phase 3 | Postoperative Pain | - | - |
Bupivacaine HCl | Phase 3 | Postoperative Pain | - | - |
Bupivicaine HCl | Phase 2 | Postoperative Pain | - | - |
HTX-034 | Phase 2 | Bunions | - | - |
Bupivacaine HCI (Marcaine) | Phase 2 | Postoperative Pain | - | - |
aprepitant | Phase 2 | Postoperative Pain | - | - |
Bupivacaine HCI without epinephrine | Phase 2 | Post-Operative Pain | - | - |
Ketorolac | Phase 2 | Postoperative Pain | - | - |
HTX-011B | Phase 2 | Postoperative Pain | - | - |
B10 L-BPA Injection | Phase 2 | Meningioma | - | - |
HTX-011A | Phase 2 | Postoperative Pain | - | - |
Bupivacaine HCl without epinephrine | Phase 2 | Postoperative Pain | - | - |
Frequently asked questions
What is in Heron Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 13 drug candidates in Heron Therapeutics, Inc.'s (HRTX) pipeline across Phase 3, Phase 2. Its lead program is APF530 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Heron Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Heron Therapeutics, Inc. (HRTX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track HRTX biotech catalysts?→
Add HRTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Heron Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.